Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
Regulatory Approval
|
Mid-range Performer
985.9500
-1.95
(
-0.20
%)
NSE
Oct 08, 2025
15:30 PM
Volume:
858.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
11 Aug 2023
Regulatory Approval
985.95
-0.20%
US quarterly revenue at historical high
Neutral:
Zydus Lifesciences Ltd.
by
Motilal Oswal
Target: 610
Target
Motilal Oswal
Zydus Lifesciences Ltd. is trading
below its 30 day SMA
of 1013.4
More from Zydus Lifesciences Ltd.
Recommended
Market trades flat, P N Gadgil Jewellers' Q2FY26 revenue rises 31% YoY
Trendlyne Marketwatch |
08 Oct 2025, 03:29PM
Five stocks to buy from analysts this week - October 7, 2025
The Baseline |
07 Oct 2025, 04:28PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020